Research Articles
Powering the Brain: How Mitochondrial Transplantation Could Revolutionize Stroke Recovery
Explore how mitochondrial transplantation offers a promising new approach to treating stroke-induced brain injury by giving brain cells a power transplant.
The Tiny Switch That Heals a Broken Heart: A MicroRNA's Story
Discover how MicroRNA-147 could revolutionize heart attack recovery by inhibiting inflammation and apoptosis through targeting HIPK2.
The Double-Edged Sword: How a Life-Saving TB Drug Can Sometimes Harm the Liver
Explore how Isoniazid, a life-saving TB drug, can cause liver damage through oxidative stress and apoptosis in HepG2 cells.
Marine Marvel: How a Sea Sponge Compound Fights Leukemia at the Molecular Level
Discover how dideoxypetrosynol A from marine sponges fights leukemia through cell cycle arrest and apoptosis mechanisms.
GLIPR1-ΔTM and Docetaxel: A Powerful Alliance Against Prostate Cancer
Discover how GLIPR1-ΔTM synergizes with docetaxel to enhance cell death and suppress resistance in prostate cancer treatment.
How a Tiny RNA Molecule Influences Breast Cancer Growth
Discover how microRNA-421 and PDCD4 interact to influence breast cancer progression, with implications for diagnosis and treatment.
Double-Barrel Attack: Simultaneously Targeting ErbB1 and ErbB2 to Combat Cholangiocarcinoma
Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy
A New Guard for the Eyes: How a Common Cholesterol Drug Could Combat Diabetic Blindness
Discover how fenofibrate, a common cholesterol drug, shows promise in protecting against diabetic retinopathy by reducing oxidative stress in retinal cells.
Stopping Cancer in Its Tracks: How a Novel Compound Fights Colon Cancer Spread
Discover how the Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis while improving survival in mice.
MLAA-22: The 'Smart Bomb' Antigen Revolutionizing Leukemia Treatment
Discover how MLAA-22, a novel antigen identified through computational biology, is transforming leukemia treatment with its precision targeting capabilities.